Printer Friendly

PLC SYSTEMS PRESIDENT RUDKO ACKNOWLEDGES COMPLETION OF CHRONIC ANIMAL STUDIES AT HARVARD UNIVERSITY MEDICAL SCHOOL

 PLC SYSTEMS PRESIDENT RUDKO ACKNOWLEDGES COMPLETION OF
 CHRONIC ANIMAL STUDIES AT HARVARD UNIVERSITY MEDICAL SCHOOL
 NEW YORK, Nov. 9 /PRNewswire/ -- In response to a question today at an investment community meeting in New York, Dr. Robert I. Rudko, president and chief executive officer of PLC Systems (AMEX: PLC, PLCE) acknowledged that chronic animal studies at Harvard University Medical School have been completed and results are positive. A technical paper describing these studies has been submitted to the American Association for Thoracic Surgery.
 PLC is currently in Phase II clinical studies of the transmyocardial revascularization procedure (TMR) and expects additional papers to be presented by clinical investigators on this subject.
 The proprietary heart laser, an experimental device, is used for a new medical procedure on the beating human heart, which can offer an alternative to conventional surgical operations such as heart bypass or angioplasty. This procedure creates new channels for blood to flow to the heart muscle.
 PLC Systems Inc. develops, manufactures and markets medical laser systems, accessories and related surgical products.
 -0- 11/9/92
 /CONTACT: Dr. Robert Rudko, president and CEO of PLC Systems, 508-478-5991/
 (PLC PLCE) CO: PLC Systems Inc. ST: New York IN: MTC SU:


JB-LS -- LA023 -- 8852 11/09/92 15:45 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 9, 1992
Words:207
Previous Article:ROBIN ROSE ICE CREAM TO HAVE VETERAN'S DAY SPECIAL, NOV. 11
Next Article:TOYOTA'S ATLANTA AREA RETAIL TRUCK SALES CLIMB IN OCTOBER
Topics:


Related Articles
PLC SYSTEMS INC. SHIPS HEART LASER TO TEXAS HEART INSTITUTE
HARVARD, TEXAS HEART DATA SHOW IMPROVED BLOOD FLOW, REDUCED ANGINA AND DEFECT-SIZE IN HEART PATIENTS TREATED WITH TMR SURGERY PIONEERED BY PLC SYSTEMS
New Clinical Study Supports PLC Systems' Heart Laser as an Adjunct to Minimally Invasive (Beating Heart) Bypass Surgery
PLC Systems Board of Directors Prepares Company For The U.S. Launch of The Heart Laser
PLC SYSTEMS INC. Reports Financial Results For The First Quarter Ended March 31, 1997
PLC Systems Announces Long Term Follow-Up Results of TMR Using The Heart Laser
IMATRON Japan Purchases Additional Heart Laser TMR Systems From PLC Systems, Inc.
PLC Systems Inc. Secures First Round of $20 Million Financing
PLC Systems Inc. Secures Second $10 Million Investment From a $20 Million Convertible Debenture Financing
Research Study Indicates That TMR Using The Heart Laser System Enhances The Effectiveness Of Gene Therapy For Heart Disease

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters